Company: AMWL
Filing Date: 2025-02-12
Form Type: 10-K
Source: 0000950170-25-019024
Chunk: 224

Company: American Well Corp
Filing Date: 2025-02-12
Form: 10-K
Item: Item 1B
Chunk 224
---
 computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:  

        Years Ended December 31,

        2024

        2023

        2022

        Unvested restricted stock units

        1,354,040

        1,119,107

        884,350

        Unvested performance market-based stock units

        775,880

        1,335,803

        1,280,114

        Options to purchase shares of common stock

        427,710

        499,442

        551,998

        2,557,630

        2,954,352

        2,716,462

F-30

19. Severance and strategic transformation costs  In 2024 the Company has executed a series of individual actions, referred to as strategic transformation actions. Strategic transformation costs include one time employee termination benefits, strategic transformation consulting expenses, as well as other incremental costs resulting from these actions. Employee termination benefits are recorded in accordance with standard Company policy. Strategic transformation costs are recognized in the Company's consolidated financial statements in accordance with GAAP. Charges are recorded when such actions are approved, communicated, and/or implemented. Amounts remaining to be paid for any strategic transformation costs are $3,631 and included in accrued expenses on the consolidated balance sheet.In the twelve months ended December 31, 2024, the Company recorded charges of $20,892, in connection with individual strategic transformation actions. For the twelve months ended December 31, 2024, these charges consist of $462 recorded as cost of sales, $2,399 recorded as research and development expense, $6,842 as sales and marketing expense, and $11,189 as general and administrative expenses.

20. Subsequent Events On January 8, 2025, Amwell entered into and closed on an asset purchase agreement relating to the sale of all property and assets owned, leased or licensed by Amwell's wholly owned subsidiary, Aligned Telehealth, LLC ("Aligned"), and affiliated clinical partner, Asana Integrated Medical Group ("Asana" and together with Aligned, "APC"), which are primarily used or held for use in connection with the APC Business, subject to certain specified exclusions such as cash. In connection with such purchase and sale, the buyer assumed specified contracts and the related accounts receivable and all accounts